Regeneron Pharmaceuticals, Inc. (REGN) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 76.14B USD. 52-week range 541.00 to 859.34 USD. Trailing P/E 18.3. Data as of 2026-10-09.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines to treat various diseases worldwide. The company develops product candidates to treat eye, allergic and inflammatory, cardiovascular, metabolic, neurological, infectious, and rare diseases; and cancer, hematologic conditions. It also offers EYLEA injections for wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; diabetic retinopathy; ...